1Sayre MR, Kaufmann KH, Chen IW et al. Measurement of cardiac troponin T ia an effective method for predicting complications among emergenoy department patients with chest pain. Ann Emerg Med 1998;31:539- 49
2Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973 - 9
3Ridker N, Rifai N, Pfeffer MA et al. Long - term effects of pravastatin on plasma concentration of CRP. CARE Investigators. Circulation 1999; 100:230 - 5
5The FRAXIS Study Group. Comparison of two treatment durations ( 6 days and 14 days) of a low molecular weight heparin with a 6 - day treatment of unfractionated heparin in the initial management of unstable angina or non- Q wave myocardial infarction: FRAX. I. S. (FRAxiparin in Ischemic Syndrome) .Eur Heart J 1999;20:1553 - 1562
6Antman EM, Cohen M, Radley D, et al. Enoxaparin for unstable angina/ non- Q wave myocardial infarction: Meta- analysis of TIMI- l1B and ESSENCE.J Am Coll Cardiol 1999;33(Suppl A):351(Abstr 819- 1)
7The EPILOG Investigators. Platelet glycoprotein Ⅰb/Ⅲa receptor blockade and low- dose heparin during percutaneous coronary revascularizatiort. N Engl J Med 1997;336:1689 - 96
8The PRISM - PLUS Investigators. Inhibition of platelet glycoprotein Ⅱb/ Ⅲa receptor with tirofiban in unstable angina and non - Q wave myocardial infarction. N Engl J Med 1998;338: 1488- 97
9CAPTURE Investigators. Randomized placebo- controlled trial of abciximab befor and during coronary intervention in refractory angina:the CAPTURE study. Lancet 1997; 349: 1429 - 34
10The Fragmin and Fast Revascularization during Instability in Coronary artery disease (FRISC Ⅱ) Investigators. Invasive compared with noninvasive treatment in unstable coronary artery disease: FRISC 11 prospective randomized multicenter study. Lancet 1999; 354: 708 - 715
